Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin versus prednisolone for induction of remission in pediatric Crohn's disease
ACTRN12612000129886Phase 3Not yet recruiting
- Sponsor
- The Royal Children's Hospital
- Start
- Mar 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in Crohn's disease comparing Atorvastatin with Prednisolone conventional treatment (2 arms). Primary endpoint: Clinical remission response by PCDAI. Planned start Mar 2012; status: not yet recruiting.
02
Drugs
atorvastatinprednisolone
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on ACTRN12612000129886.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12612000129886.